FDA Inspection 1242708 — Zhejiang Tiantai Pharmaceutical Co., Ltd. (Cangshan Plant)
The FDA completed an inspection of Zhejiang Tiantai Pharmaceutical Co., Ltd. (Cangshan Plant) on May 24, 2024 in Taizhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 24, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Taizhou (China)